Bicycle Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,676 | $9,371 | $19,518 | $5,331 |
Gross Profit | 2,676 | 7,729 | 17,861 | 3,662 |
EBITDA | -63,846 | -52,475 | -45,792 | -46,488 |
EBIT | -54,117 | -47,449 | -48,156 | |
Net Income | -50,802 | -39,856 | -26,547 | -49,099 |
Net Change In Cash | 2,676 | 9,371 | 19,518 | 5,331 |
Free Cash Flow | -40,230 | -45,123 | -70,840 | -47,339 |
Cash | 890,862 | 961,363 | 456,997 | 526,423 |
Basic Shares | 68,988,858 | 51,992 | 42,560 | 42,419 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $26,976 | $14,463 | $11,697 | $10,390 |
Gross Profit | 20,404 | 10,776 | -33,183 | -22,759 |
EBITDA | -168,804 | -110,897 | -65,498 | -51,277 |
EBIT | -175,375 | -114,583 | -66,906 | -52,563 |
Net Income | -180,664 | -112,717 | -66,819 | -51,010 |
Net Change In Cash | 26,976 | 14,463 | 11,697 | 10,390 |
Free Cash Flow | -63,557 | -105,098 | -16,824 | -18,989 |
Cash | 526,423 | 339,154 | 438,680 | 135,990 |
Basic Shares | 35,592 | 29,660 | 25,061 | 19,145 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.74 |
2024-06-30 | -$0.77 |
2024-03-31 | -$0.62 |
2023-12-31 | -$1.16 |
